CSAI vs ABVX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABVX Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abivax SA American Depositary Shares (ABVX) driven by superior Momentum & Technical, Options & Structure while CSAI counters with relative strength in Growth & Margin. Fundamentally, CSAI trades at N/M Forward P/E with -164.2% operating margin (+6.1% YoY revenue) versus ABVX at N/M Forward P/E and -6270.4% operating margin (-6.8% YoY). In options structure, CSAI sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CSAI | ABVX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $765,275 | $7.1B | Larger Scale | ABVX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +6.1% | -6.8% | Higher Growth | CSAI |
| Operating Margin (TTM) Profitability | -164.2% | -6270.4% | Higher Margin | CSAI |
| Net Profit Margin Profitability | -166.5% | 0.0% | Higher Margin | ABVX |
| Return on Equity (ROE) Capital Efficiency | -214.8% | -252.3% | Higher ROE | CSAI |
| 52-Week Range Position Momentum | 4% ($0โ$7) | 12% ($63โ$149) | Stronger Trend | ABVX |
| Beta / 30D Volatility Risk Regime | 15.27ฮฒ ยท 183% Vol | 1.55ฮฒ ยท 55% Vol | Lower Realized Risk | ABVX |
| Unified Institutional Score Composite Signal | 38.7 / 100 (SELL) | 42.4 / 100 (HOLD) | Higher Composite | ABVX |